--- /home/parlparse/parldata/cmpages/lordspages/daylord2007-07-12a.html	2007-07-13 08:11:08.000000000 +0100
+++ /home/parlparse/parldata/tmp/patchtmp-daylord2007-07-12a-9n6hPr.html	2007-07-13 09:49:45.000000000 +0100
@@ -4140,14 +4140,14 @@
 
 
 <p><a name="wa_qn_10"></a>
-<a name="70712w0001.htm_wqn10"></a><a name="07071280000057"></a> asked Her Majesty&#146;s Government:</p>
+<a name="70712w0001.htm_wqn10"></a><a name="07071280000057"></a><b>Lord Bradley</b> asked Her Majesty&#146;s Government:</p>
 
 <ul><a name="07071280000160"></a>
 <p><a name="wa_qnpa_14"></a>Further to the Written Answer by Lord Hunt of Kings Heath on 18 June (<I>WA 15</I>), what is the detail of the research into Henoch-Schönlein purpura which is available on the national research register at www.dh.gov.uk/research. [HL4706]</p>
 </ul>
 
 <p><a name="wa_st_10"></a>
-<a name="07071280000058"></a> The national research register lists the following studies undertaken in the National Health Service:</p>
+<a name="07071280000058"></a><b>Baroness Royall of Blaisdon:</b> The national research register lists the following studies undertaken in the National Health Service:</p>
 a randomised, double-blind, placebo-controlled study to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schönlein purpura;a study of the incidence of rare vasculitidies in children in the West Midlands, and the outcome of children with Henoch-Schönlein purpura after five years follow-up; andHenoch-Schönlein purpura (HSP) in childhood&#151;how do abnormalities in immunoglobulin A relate to the pathogenesis of HSP.<a name="wa_subhd_11"></a>
 <a name="70712w0001.htm_sbhd11"></a><h3 align="center"><a name="07071280000013"></a>House of Lords: Select Committees</h3>
 
